Dose-escalated radiation therapy for glioblastoma

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 2 trial. Mid-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 19 Feb 2025: Trial registered, NCT06835803
  2. 14 Apr 2025: Trial started, NCT06835803

The trials

NCT06835803: Enhanced Local Intensified Radiation Therapy in Elderly Glioblastoma: A Phase 2 Hybrid Randomized Trial

State
Under way
Phase
Phase 2
People
56 planned
Started
14 Apr 2025
Primary completion
31 Mar 2028
Arms
Dose-escalated hypofractionated radiation over 3 weeks
Results
None posted
  1. 19 Feb 2025: Trial registered
  2. 14 Apr 2025: Trial started

How the status changed

  1. 19 Nov 2026: First set: Phase 2 trial

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.